Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach
A novel aspiration in treatment of chronic disease like diabetes associated with other non communicable disease risk factors, such as hypertension is to provide greater therapeutic effect, overcome the side effects by complex therapeutic regimen and to improve patient compliance upon administering c...
Saved in:
Published in | Pakistan journal of pharmaceutical sciences Vol. 24; no. 2; pp. 155 - 163 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Pakistan
Pakistan Journal of Pharmaceutical Sciences
01.04.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A novel aspiration in treatment of chronic disease like diabetes associated with other non communicable disease risk factors, such as hypertension is to provide greater therapeutic effect, overcome the side effects by complex therapeutic regimen and to improve patient compliance upon administering combinational transdermal delivery of Glibenclamide (G) and Atenolol (A) which have not been tested literally. Hence, the present study was designed to develop a transdermal patch containing Glibenclamide and Atenolol using blends of different polymeric combinations such as Hydroxy propyl methyl cellulose (HPMC), Poly vinyl pyrolidone (PVP) and Carbopol (CP). The patches were subjected to physicochemical parameters, in-vitro and in-vivo drug release and in-vitro skin permeation studies. Good results were obtained in all the evaluated parameters. The drug release of all formulation follows zero order kinetics by diffusion mechanism of non fickian diffusion type. In-vitro transdermal permeation studies by using rat & goat skin and finally in-vivo studies by using rabbits were carried out for the optimized formulation (GA4 HPMC 1%, PVP 0.5%, CP 0.5%). The developed transdermal delivery system containing Glibenclamide & Atenolol might be a milestone in the combinational therapy of diabetes and hypertension. |
---|---|
AbstractList | A novel aspiration in treatment of chronic disease like diabetes associated with other non communicable disease risk factors, such as hypertension is to provide greater therapeutic effect, overcome the side effects by complex therapeutic regimen and to improve patient compliance upon administering combinational transdermal delivery of Glibenclamide (G) and Atenolol (A) which have not been tested literally. Hence, the present study was designed to develop a transdermal patch containing Glibenclamide and Atenolol using blends of different polymeric combinations such as Hydroxy propyl methyl cellulose (HPMC), Poly vinyl pyrolidone (PVP) and Carbopol (CP). The patches were subjected to physicochemical parameters, in-vitro and in-vivo drug release and in-vitro skin permeation studies. Good results were obtained in all the evaluated parameters. The drug release of all formulation follows zero order kinetics by diffusion mechanism of non fickian diffusion type. In-vitro transdermal permeation studies by using rat & goat skin and finally in-vivo studies by using rabbits were carried out for the optimized formulation (GA4 HPMC 1%, PVP 0.5%, CP 0.5%). The developed transdermal delivery system containing Glibenclamide & Atenolol might be a milestone in the combinational therapy of diabetes and hypertension. Keywords: Transdermal patches, glibenclamide, atenolol, diabetes, hypertension. A novel aspiration in treatment of chronic disease like diabetes associated with other non communicable disease risk factors, such as hypertension is to provide greater therapeutic effect, overcome the side effects by complex therapeutic regimen and to improve patient compliance upon administering combinational transdermal delivery of Glibenclamide (G) and Atenolol (A) which have not been tested literally. Hence, the present study was designed to develop a transdermal patch containing Glibenclamide and Atenolol using blends of different polymeric combinations such as Hydroxy propyl methyl cellulose (HPMC), Poly vinyl pyrolidone (PVP) and Carbopol (CP). The patches were subjected to physicochemical parameters, in-vitro and in-vivo drug release and in-vitro skin permeation studies. Good results were obtained in all the evaluated parameters. The drug release of all formulation follows zero order kinetics by diffusion mechanism of non fickian diffusion type. In-vitro transdermal permeation studies by using rat & goat skin and finally in-vivo studies by using rabbits were carried out for the optimized formulation (GA4 HPMC 1%, PVP 0.5%, CP 0.5%). The developed transdermal delivery system containing Glibenclamide & Atenolol might be a milestone in the combinational therapy of diabetes and hypertension. A novel aspiration in treatment of chronic disease like diabetes associated with other non communicable disease risk factors, such as hypertension is to provide greater therapeutic effect, overcome the side effects by complex therapeutic regimen and to improve patient compliance upon administering combinational transdermal delivery of Glibenclamide (G) and Atenolol (A) which have not been tested literally. Hence, the present study was designed to develop a transdermal patch containing Glibenclamide and Atenolol using blends of different polymeric combinations such as Hydroxy propyl methyl cellulose (HPMC), Poly vinyl pyrolidone (PVP) and Carbopol (CP). The patches were subjected to physicochemical parameters, in-vitro and in-vivo drug release and in-vitro skin permeation studies. Good results were obtained in all the evaluated parameters. The drug release of all formulation follows zero order kinetics by diffusion mechanism of non fickian diffusion type. In-vitro transdermal permeation studies by using rat & goat skin and finally in-vivo studies by using rabbits were carried out for the optimized formulation (GA4 HPMC 1%, PVP 0.5%, CP 0.5%). The developed transdermal delivery system containing Glibenclamide & Atenolol might be a milestone in the combinational therapy of diabetes and hypertension. |
Audience | Academic |
Author | Anitha, Posina Saleem, Mohamed T S Umasankari, Kommireddy Reddy, Boddu Praveen Ramkanth, Sundarapandiyan Chetty, Madhusudhana |
Author_xml | – sequence: 1 givenname: Posina surname: Anitha fullname: Anitha, Posina email: posina.anitha26@gmail.com organization: Department of Pharmaceutics, Annamacharya College of Pharmacy, New Boyanapalli, Rajampet, Kadapa (Dt), Andhra Pradesh, India. posina.anitha26@gmail.com – sequence: 2 givenname: Sundarapandiyan surname: Ramkanth fullname: Ramkanth, Sundarapandiyan – sequence: 3 givenname: Mohamed T S surname: Saleem fullname: Saleem, Mohamed T S – sequence: 4 givenname: Kommireddy surname: Umasankari fullname: Umasankari, Kommireddy – sequence: 5 givenname: Boddu Praveen surname: Reddy fullname: Reddy, Boddu Praveen – sequence: 6 givenname: Madhusudhana surname: Chetty fullname: Chetty, Madhusudhana |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21454164$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtLAzEQx3OoqK1-BQl48OJKspt9xJuILyjoQcHbMk1m20g2WbOpoF_Ar21s9SDIHMJMfvOf15RMnHc4IfuccZ5VjD_vkek4vjBWCSnlLtnLuSgFr8Q--XwIOECAaLw7pcZlbyYGT8HprfPmqVqlfxUxmI8NRn1HYwA3agw9WDpAVCuqvItgnHFLurRmgU5Z6I3GjRREdN56e04hgf3CuI1SSoZhCB7U6oDsdGBHPPx5Z-Tp-urx8jab39_cXV7Ms2Ve1zFLTTe6KRhvuKxFU0vWlQyYXCjWFF2da1GISvNGKKhq2TEloFISE1Nx5KUuZuRkq5vKvq5xjG1vRoXWgkO_HtumlHXFJc8Tebwll2CxNa7zaWj1TbcXuSyFKEteJursHyqZxt6knWBnUvxPwtFPA-tFj7odgukhvLe_Jym-AJTRiQs |
ContentType | Journal Article |
Copyright | COPYRIGHT 2011 Pakistan Journal of Pharmaceutical Sciences |
Copyright_xml | – notice: COPYRIGHT 2011 Pakistan Journal of Pharmaceutical Sciences |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EndPage | 163 |
ExternalDocumentID | A295445515 21454164 |
Genre | Journal Article |
GeographicLocations | Pakistan |
GeographicLocations_xml | – name: Pakistan |
GroupedDBID | --- 123 36B 53G A8Z ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF DIK EBD EBS ECM EIF EJD EMB EMOBN EOJEC ESTFP F5P IAO INH INR ITC MK0 NPM OBODZ OK1 P2P P6G SV3 TR2 7X8 |
ID | FETCH-LOGICAL-g277t-4168d8301819748790f50a09bc083f72d4346d184ca679f0c4a6c9e50a61e15d3 |
ISSN | 1011-601X |
IngestDate | Wed Jul 24 15:52:09 EDT 2024 Fri Feb 23 00:02:01 EST 2024 Wed Oct 25 09:24:13 EDT 2023 Sat Sep 28 07:51:17 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-g277t-4168d8301819748790f50a09bc083f72d4346d184ca679f0c4a6c9e50a61e15d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21454164 |
PQID | 859761912 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_859761912 gale_infotracmisc_A295445515 gale_infotracacademiconefile_A295445515 pubmed_primary_21454164 |
PublicationCentury | 2000 |
PublicationDate | 2011-Apr 20110401 |
PublicationDateYYYYMMDD | 2011-04-01 |
PublicationDate_xml | – month: 04 year: 2011 text: 2011-Apr |
PublicationDecade | 2010 |
PublicationPlace | Pakistan |
PublicationPlace_xml | – name: Pakistan |
PublicationTitle | Pakistan journal of pharmaceutical sciences |
PublicationTitleAlternate | Pak J Pharm Sci |
PublicationYear | 2011 |
Publisher | Pakistan Journal of Pharmaceutical Sciences |
Publisher_xml | – name: Pakistan Journal of Pharmaceutical Sciences |
SSID | ssj0064999 |
Score | 1.9852074 |
Snippet | A novel aspiration in treatment of chronic disease like diabetes associated with other non communicable disease risk factors, such as hypertension is to... |
SourceID | proquest gale pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 155 |
SubjectTerms | Administration, Cutaneous Animals Atenolol Atenolol - administration & dosage Atenolol - chemistry Atenolol - pharmacokinetics Diabetes Dosage and administration Drug therapy Glibenclamide Glyburide - administration & dosage Glyburide - chemistry Glyburide - pharmacokinetics Goats Hypertension In Vitro Techniques Male Rabbits Rats Rats, Wistar |
Title | Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21454164 https://search.proquest.com/docview/859761912 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWcnHoputdtWvBQpIdYgWlRW29Gt7RBCwOxAd8EiqRqI7EU2HIA5wf6Lf3LzojU5vaQ9iLYkiyTnudZODOPhLzxlcelVMxJVBo5PNTcEVy5TqhFIlTqjtwyUPz23T-b8a9zb97r_WpVLW2L5FTe_rWv5H-kCudArtgl-w-SrR8KJ-A1yBeOIGE43knGk7U21N0mdb7MnJtlsc4toxK8ucmxs9cyMt_W3mGBBkqhTr5CYlVZFp8XZq-Ik89YcZJJQMpSmdzCGPxq0JFXpjEaJgLRdLWGWHGSt51c65VmbVqK60Vn7dwa3tqhH4NmMamnSb6xO3qb9NPqEmS_MAVEuOgBxj1Ty10D6gswcdos7OYLAcb9ZHpae7izldiI7FKYfvrzfLUCFa8soa5qVm95e7GjHn_LW590x3_RHr_R6fgciDvnbaVvGrctuEctDc4Ma_AeCfcY06EcvEvvgBy4DGtHP3w5r0y-j2FjmVa33_Snfd-LWkrvZfqA3LcToWODoYekp7NH5NhOajeg06YNbzOgx3TSMJrvHpOfLaANaAUzCoKgFmZ0H2Y0T2kLZrSEGW1gRjswKx9VwewdFbQDMlqB7AmZffo4fX_m2B08nB-jICgc8PZDFbpICgdxaxhEw9QbimGUSPD802CkuMt9xUIuhR9E6VBy4ctIwz0-08xT7lNymOWZfk6oKHc6CCMRBUghCQqQsUAkgcbN0wOW9slb_Mlj_PfC9KSw7SXwaWQ4ixsJ9slR507Qp7JzmVZCi_ESFiFmOt9u4hCCb59FbNQnz4ww42tDCRMj3z9Mlr-48yheknsNwI_IYbHe6lfg3xbJ6xJbvwGJzrbU |
link.rule.ids | 315,786,790 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preparation%2C+in-vitro+and+in-vivo+characterization+of+transdermal+patch+containing+Glibenclamide+and+Atenolol%3A+a+combinational+approach&rft.jtitle=Pakistan+journal+of+pharmaceutical+sciences&rft.au=Anitha%2C+Posina&rft.au=Ramkanth%2C+Sundarapandiyan&rft.au=Saleem%2C+Mohamed+T.S&rft.au=Umasankari%2C+Kommireddy&rft.date=2011-04-01&rft.pub=Pakistan+Journal+of+Pharmaceutical+Sciences&rft.issn=1011-601X&rft.volume=24&rft.issue=2&rft.spage=155&rft.externalDocID=A295445515 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-601X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-601X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-601X&client=summon |